Unexpected regiospecific alkylation of the antitumor agent N2-methyl-9-hydroxyellipticinium acetate with N, O or S donors
- 1 January 1983
- journal article
- Published by Elsevier in Tetrahedron Letters
- Vol. 24 (4) , 365-368
- https://doi.org/10.1016/s0040-4039(00)81408-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Metabolic activation and drug toxicityJournal of Medicinal Chemistry, 1982
- Copper(II)-induced oxidations of aromatic substrates: catalytic conversion of catechols to o-benzoquinones. Copper phenoxides as intermediates in the oxidation of phenol, and a single-step conversion of phenol, ammonia, and oxygen into muconic acid mononitrileJournal of the American Chemical Society, 1981
- Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide systemJournal of Medicinal Chemistry, 1981
- Deshydrogenation d'alcools en composes carbonyles par le systeme CuCl/O2/LigandeTetrahedron, 1980
- Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)Published by Springer Nature ,1980
- Cleavage of carbon-carbon bonds. Copper(II)-induced oxygenolysis of o-benzoquinones, catechols, and phenols. On the question of nonenzymic oxidation of aromatics and activation of molecular oxygenJournal of the American Chemical Society, 1978
- Bioactivation as a Model for Drug Design Bioreductive AlkylationScience, 1977
- Alkaloids of Ochrosia maculata Jacq. (Ochrosia borbonica Gmel.)Journal of Pharmaceutical Sciences, 1968